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ABSTRACT 
 
A square wave voltammetric (SWV) method and a ﬂow injec- tion 
analysis system with electrochemical detection (FIA-EC) using a glassy 
carbon electrode were evaluated for the deter- mination of codeine in 
pharmaceutical preparations. The interference of several compounds, 
such as     acetaminophen, 
guaiacol,    parabens,    ephedrine,    acetylsalicylic    acid    and caﬀeine, 
that usually appear associated with codeine pharma- ceutical  
preparations  was  studied.  It  was  veriﬁed  that  these electroanalytical  
methods  could  not  be  used  with  acetamino- phen   present   in   the   
formulations   and   that   with   guaiacol, parabens   or   ephedrine   
present   the   use   of   the   FIA-EC system  was  impracticable.  A  
detection  limit  of  5 mmol L
-1 
and  a  linear  calibration  range  from  
40  to  140 mmol L
-1   
was obtained   with   the   SWV   method.   For   
the   ﬂow   injection analysis  procedure  a  linear  calibration  range  was  
obtained from  7  to  50 mmol L
-1   
with  a  detection  limit  of  3 mmol 
L
-1 
and   the   FIA-EC   system   allowed   a   sampling   rate   of   115 
samples  per  hour.  The  results  obtained  by  the  two  methods, SWV 
and FIA-EC, were compared with those obtained using reference  
methods  and  demonstrated  good  agreement,  with relative  deviations  
lower  than  4%. 
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INTRODUCTION 
 
Codeine (Fig. 1), a member of the opiate class of drug, has long been used as an 
 eﬀective analgesic and antitussive agent in pharmaceutical pre- parations. Some of the 
common side eﬀects associated with the use of codeine include drowsiness, light-
headedness, dry mouth and, of course, euphoria. Since codeine belongs to the opiate 
group, whose more important 
 
 
 
 
Figure  1.    Structure of codeine. 
 
 
 
 
eﬀects are on the central nervous system, it can produce psychological dependence and is one of 
the main limitations of its clinical    use. 
A sensitive and speciﬁc analytical method is therefore essential for studying 
the bioavailability of codeine from oral  formulations. Surprisingly, relatively few 
procedures have been proposed for the determi- nation of codeine. Assay methods 
reported in the British
[1] 
and United States
[2] 
Pharmacopoeias are based on extraction of 
the base followed by non- aqueous titrimetry and HPLC. Other techniques for determining 
codeine include spectrophotometry,
[3] 
spectroﬂuorimetry,
[4] 
potentiometry
[5,6] 
and gas 
chromatography.
[7] 
Electrochemical methods for the determination of codeine are also 
described in the literature but they involve derivatization prior to the use of diﬀerential 
pulse polarography
[8] 
and the use of a Naﬁon/ruthenium oxide pyrochlore  chemically  
modiﬁed electrode.
[9] 
Many of these methods require several manipulation steps such as 
liquid– liquid extraction, which are time consuming and solvent-usage intensive, plus 
sophisticated instrumentation and training. In order to quantify the bioavailability of 
codeine from oral formulations this paper reports the development of an 
electroanalytical methodology appropriate for routine analysis. A square-wave 
voltammetric (SWV) method and a ﬂow injection analysis with electrochemical 
detection (FIA-EC) system for the determina- tion of codeine in commercial 
pharmaceutical preparations using a glassy carbon electrode will be described. 
 
 
 
EXPERIMENTAL SECTION 
 
Apparatus 
 
For the voltammetric measurements a 663 VA Metrohm cell containing a glassy 
carbon  working electrode  (Metrohm,  d ¼ 2.0 mm),  a glassy  carbon rod   counter   
electrode   (Metrohm)   and   an   Ag/AgCl   (3 mol L
-1     
KCl) reference electrode 
(Metrohm) attached to an Autolab PSTAT 10 potentio- stat/galvanostat running with 
model GPES (EcoChimie, Netherlands). 
The FIA system  developed  consists of a Gilson Minipuls 3 peristaltic pump to 
propel the solutions, a Rheodyne 5020 valve to inject the solutions and  as  detector  unit  
an  electrochemical  system  consisting  of  a  VA  641 Metrohm  detector  and  a  656  
Metrohm  electrochemical  wall-jet  cell.  The cell  consists  of  three  electrodes:  a  
Metrohm  glassy  carbon  electrode  as  the working  electrode a Metrohm gold  electrode 
as the  auxiliary electrode  and a Metrohm Ag/AgCl (3 mol L
-1  
KCl) as the reference 
electrode. To link the diﬀerent components of the FIA set-up, Omniﬁt Teﬂon tubing 
(0.8 mm i.d.) and  Gilson  end  ﬁttings  were  used.  Additional  home-made  dampers  
 were 
used as described elsewhere.
[10] 
To record analytical signals, a Kipp  & Zonen (model 
BD 112) data recorder was   used. 
The glassy carbon working electrodes were manually cleaned and polished with 
abrasive every day, ﬁrst with 1 mm Al2O3 (BDH) and then with deionised water 
only. 
A Metrohm E520 pH-meter was used for the pH    measurements. 
For  the  HPLC  reference  method,
[1]   
a  Sykam  model  A  1210  liquid 
chromatograph,  equipped  with  a  UV  visible  detector  (A ¼ 285 nm)  model 3200  was  
used.  Separation  of  sample  components  was  accomplished  using a Nucleosil 100-10 
C18 column (250 x 4 mm, 10 mm particle size, Macherey– Nagel,  Germany).  The  
separation  was  carried  out  at  room  temperature using  0.01 mol L
-1   
sodium  
octanesulphonate  in  a  mixture  of  55  volumes of  water,  45  volumes  of  methanol,  and  
1  volume  of  glacial  acetic  acid  as the  mobile  phase  with  a ﬂow  rate  of  1 mL  per  
minute. 
 
 
  
 
 
Reagents and Solutions 
 
Analytical  grade  reagents  were  used  without  any  additional  puriﬁca- tion.  
Deionised  water  with  conductivity  less  than  0.1 mS cm
-1    
was  used throughout.  
The  pH  3  acetate  buﬀer  used  for  the  voltammetric  determina- tions was prepared by 
dilution to 100 mL of 3.7 mL of 0.2 mol L
-1  
NaOAc and  46.3 mL  of  0.2 mol L
-1  
HOAc.  The  supporting  electrolyte used  as  car- rier  in  the  FIA  system  was  prepared  
by  dilution  to  100 mL  of  6.2 mL  of 
0.2 mol L
-1  
K2HPO4  and  43.8 mL  of  0.2 mol L
-1  
KH2PO4.  For  the  HPLC 
reference method all the solvents used were of HPLC grade. Prior to use, the solvents 
were ﬁltered and the air removed with helium. 
 
 
Standard and Sample Preparation 
 
Codeine stock solutions (10
-3 
mol L
-1
) were prepared by dissolution of weighed    
amounts    of    codeine    hydrochloride    (Uquipa,    Portugal)    in 
0.01 mol L
-1   
HClO4.  For  the  voltammetric  method  accurate  volumes  of the  
solution  obtained  were  added  in  the  cell  to  the  buﬀer  in  order  to obtain   codeine   
concentrations   between   40   and   140 mmol L
-1
.   For   the FIA   system,   more   
diluted   solutions,   between   7   and   50 mmol L
-1
,   were prepared  by  careful  dilution  
of  the  stock  solution.  All  these  solutions  were prepared daily. 
The determination of codeine was performed in commercial tablets and oral 
solutions available in Portugal and Belgium. The dosage forms analysed     were     
SEDOTUSSE     oral     solution     (Helfarma,       Portugal), 
  
 
 
VACALIBOM   oral   solution   (Moreno,   Portugal),   DOLVIRAN   tablets 
(Bayer,   Portugal),   CODIS   tablets   (Reckitt   &   Colman,   Belgium)   and 
NOGRIMINE  tablets  (Omega  Pharma,  Belgium).  The  nominal  content  of the  
labelled  codeine  is  in  Table  1,  and  the  preparation  of  the  samples  for analysis was  
carried out  as follows.  Ten tablets were powdered in an agate mortar, homogenised and 
an appropriate amount, enough to obtain a con- centration  within  the  calibration  curve  
range,  was  carefully  weighed  and dissolved   in  0.01 mol L
-1    
HClO4.  Oral  
solutions  were  just  diluted  with 
0.01 mol L
-1  
HClO4  to  achieve  the  appropriate  concentration. 
 
RESULTS   AND  DISCUSSION 
 
Eﬀect of pH 
 
Considering the structure of codeine it is surprising that until the middle 80 s it 
was considered non-electroactive and at present only a few electroanalytical studies are 
reported. 
The electrochemical oxidation behaviour of codeine was studied using a glassy 
carbon electrode over a very wide pH range by diﬀerential pulse voltammetry, Fig. 2. 
The oxidation always occurs at very high positive potentials and is thus impossible to 
study using platinum or gold as working electrodes. 
The oxidation mechanism of codeine is complex with adsorption occurring at the 
electrode surface and is also pH dependent. Three oxidation peaks were observed 
corresponding to the diﬀerent groups in the molecule, shown in Fig. 1. Due to the very 
high positive potentials the detection of the peaks with higher potentials is limited by 
solvent evolution. At very acid pH only one oxidation peak can be observed. For pH 
values between 4 and 7 two oxidation peaks occurs and at pH>8 three peaks can be 
detected. The position of all peaks was pH dependent and with a slope of 59 mV per 
pH unit. The same number of electrons and protons are involved in the oxidation 
mechanism and the pK'""9. Considering the current for the ﬁrst oxidation peak, Fig. 2, 
it reaches the maximum value for pH ¼ 6. 
 
Square Wave Voltammetry 
 
Square wave voltammetry (SWV) is a voltammetric technique that has better 
sensitivity than DPV and enables more rapid determinations and was chosen for 
establishing a voltammetric methodology for the determination of codeine in 
pharmaceutical preparations. As seen in Fig. 2 the oxidation of 
  
 
 
 
Figure  2.    Plots  of  Ep   and  Ip   vs.  pH  from  diﬀerential  pulse  voltammograms   of 
0.1 mmol L-1   solutions  of  codeine  in  0.2 mol L-1   ionic  strength  buﬀer  
electrolyte: (gœ)  ﬁrst  peak;  (m)  second  peak;  (^)  third  peak.  Scan  rate  5 mV s-1.  
Slope  of dotted  line  59 mV/pH  unit. 
 
 
codeine is a complex mechanism and three oxidation peaks can be observed at high pH. 
This led to the selection of pH ¼ 3, where only one  peak appears, for the SWV 
electroanalytical  determinations. 
The optimal experimental SWV parameters were deduced: frequency, f ¼ 150 Hz,   
pulse   amplitude,   Es ¼ 50 mV   and   solution   ionic   strength, I ¼ 0.2 mol L
-1      
and    good    linearity    was    obtained    in    the    range    of 40–140 mmol L
-1  
codeine,  Fig. 3. The detection limit, evaluated as the con- centration of codeine 
corresponding to three times the standard deviation of the  background signal,
[11]  
was  
found  to  be  5 mmol L
-1
. 
 
Flow Injection Analysis with Electrochemical Detection 
 
Flow injection analysis with electrochemical detection (FIA-EC), compared with 
stationary or continuous ﬂow hydrodynamic voltammetry, has the advantage of a drastic 
decrease in adsorption associated with the use of a ﬂow system. Since it was found, from 
the diﬀerential pulse voltammetric study, Fig. 2, that the highest current for the ﬁrst 
oxidation peak was obtained at pH 6 this buﬀer was chosen as supporting   electrolyte. 
  
 
 
 
Figure  3.    Successive   square   wave   voltamograms   in   pH 3   0.2 mol L-1     buﬀer 
electrolyte    of    codeine:    41.4,    61.8,    82.0,    102.0,    121.8,    and    141.4 mmol L-
1. Frequency  150 Hz;  pulse  amplitude  50 mV. 
 
 
The FIA manifold used in the determination of codeine was gradually optimised 
by the univariant method with the purpose of allowing the intro- duction  of  samples  
without  pre-treatment  and  maximising  the  sample  rate and  reproducibility.  Hence,  a  
single  channel  manifold  was  set  up  (Fig.  4) and   the   inﬂuence   of   several   parameters,   
namely   the   pH   of   supporting electrolyte, the working electrode potential, the ﬂow rate 
(Q1), the injection volume (A), and the length of the reactor (R) was assessed. The study 
of the best    working    conditions    of    the    FIA    manifold    was    made    using    a 
100 mmol L
-1  
solution  of  codeine. 
The potential of the working electrode was optimised studying the variation of 
the current peak height with an applied ﬁxed potential between þ1.0 and þ1.5 V. The 
peak current increased until a  maximum  at  the applied potential of þ1.3 V and above 
this the peak remained virtually constant. Thus the value of þ1.3 V was chosen and used 
in  subsequent trials. 
The selection of the most adequate ﬂow rate was dependent on limita- tions of the 
wall-jet cell whose dead volume is about 1 mL.
[12]  
It was veriﬁed that using ﬂow rates 
higher than 2.4 mL min
-1 
was not satisfactory since they produce  high  pressures  within  
the  system,  and  consequently  irreproducible signals, whereas lower ﬂow rates gave 
reproducible signals but they compro- mise the sampling rate. Therefore, the value of 2.4 
mL min
-1  
was chosen. 
  
 
 
 
Figure  4.    Flow  injection  analysis  manifold  used  for  codeine  determination:  A— 
sample, B—peristaltic pump, E—inlet for K2HPO4/KH2PO4  buﬀer support electro- 
lyte,   Q1—ﬂow   rate   2.4 mL min-1,   V—injection   valve   (78 mL),   R—mixing   
coil 
(30 cm), WJD—wall-jet electrochemical detector, D—outlet for   waste. 
 
With the purpose of optimising the injection volume, loops were made of the 
same Teﬂon tubing that was used for the other parts of the system (0.8 mm i.d.) with 
lengths between 5 and 15 cm. A 10 cm loop was selected since higher injection volumes 
compromised sampling rate while lower ones produced less reproducible analytical signals. 
The injection volume, which was afterwards determined by titration of a solution of known 
concentration,
[13] 
corresponded to 78 mL. 
The optimisation was concluded with the selection of the reactor length in which 
the mixture of the sample plug with the electrolyte takes place. Reactors with lengths 
between 20 and 40 cm were tested and it was veriﬁed that for lengths less than 30 cm, 
mixing between sample and electro- lyte was incomplete and led to irreproducible 
signals. On the other hand greater lengths of the mixing coil signiﬁcantly 
compromise the sampling rate. Therefore a 30 cm reactor length was selected. 
With  these  optimised  parameters,  the  FIA-EC  system  allowed  sam- pling  rates  
of  about  115  samples  per  hour.  A  linear  calibration  range  for codeine,  between  7  and  
50 mmol L
-1
,  and  a  detection  limit  of  3 mmol L
-1
, evaluated  as  the  concentration  
corresponding  to  three  times  the  standard deviation  of  the  background  signal,
[11]  
were 
obtained. 
 
 
Interferents on the Determination of Codeine in 
Pharmaceutical Preparations 
 
In order to evaluate the quality of the results obtained with the voltammetric 
method and with the FIA manifold determinations were performed using commercially 
available pharmaceutical preparations. However, although in some European countries 
pharmaceutical formula- tions exist containing only codeine as active substance, in 
other countries, such as Portugal and Belgium, it appears associated with active 
ingredients such  as  acetaminophen,  acetylsalicylic  acid  (ASA)  or  caﬀeine.  For     
this 
  
 
 
reason a study of the possible interference of these compounds in the determination of 
codeine by SWV and FIA-EC was carried out. 
The oxidation behaviour of acetaminophen was evaluated at pH 3 and 
6 and one oxidation peak was observed at a potential lower than that observed for 
codeine at this pH with a potential separation between the oxidation peaks near 500 mV. 
So if acetaminophen and codeine were present in the same concentration in the 
pharmaceutical formulations this would not cause any problem to use the SWV method. 
However, the concentration of acetaminophen in pharmaceutical formulations is 
approximately 50 times higher than the concentration of codeine. This means that the 
peaks will overlap making the quantitative determination of codeine using SWV or FIA-
EC   impossible. 
Other compounds, such as guaiacol and parabens, that appear in some 
pharmaceutical preparations together with codeine also present oxidation peaks at lower 
oxidation potentials than codeine. But since their con- centration is similar to the 
concentration of codeine in pharmaceutical preparations and the peaks are well 
separated, it is  possible  to  use the SWV method for codeine   quantiﬁcation. 
The oxidation behaviour of other constituents that appear commonly with codeine 
was also studied. It was veriﬁed that ephedrine and acetyl- salicylic acid do not have  
any  oxidation  peak  at  the  pHs  studied. Caﬀeine, another compound very often used, 
has an oxidation peak at potentials higher than that of codeine so that there is no 
interference in determinations  using  SWV  or  FIA-EC. 
 
 
Determination of Codeine in Pharmaceutical Preparations 
 
For the evaluation of the developed SWV and FIA-EC methodology, ﬁve 
pharmaceutical preparations containing codeine were chosen, three from Portugal  and 
two from Belgium, Table  1. 
The FIA system was calibrated as described and Fig. 5 shows the results obtained 
in the determination of codeine in pharmaceutical prepara- tions, corresponding to the 
injection in triplicate of ﬁve standard solutions and three samples. 
The accuracy of the results provided by the developed SWV and FIA-EC 
methodology (CD) was assessed by comparing them with the results obtained from the 
reference methods (CR), i.e., HPLC for oral solutions and titrimetry for tablets.
[1] 
The 
relative standard deviation of the proposed methodologies was always lower than 4%. 
Table 1 lists the mean results 
obtained for three replicate determinations of ﬁve pharmaceutical prepara- tions 
commonly available  in Portugal  and Belgium. 
  
 
 
Table 1. Determination of Codeine in Commercial Pharmaceutical Preparations Using 
the Square Wave Voltammetric Method (SWV), FIA with Amperometric Detection, and 
the  Reference  Method  (HPLC  for  Oral  Solutions  and  Titrimetry for Tablets[1]) 
  
 
Formulation 
Codeine  Nominal 
Content SWVa FIA-
ECa 
Reference 
Methoda 
 
Sedotusseb 450 mg  172 mL-1 260.0 ± 6.4 — 258.1 ± 4.3 
Vacalibomb 47 mg  100 mL-1 50.0 ± 0.6 — 49.1 ± 0.5 
Dolviranc 10 mg  tablet-1 9.5 ± 0.2 9.7 ± 0.1 9.7 ± 0.4 
Codisc 8 mg  tablet-1 8.4 ± 0.2 8.2 ± 0.1 8.1 ± 0.3 
Nogriminec 30 mg  tablet-1 29.4 ± 0.4 30.6 ± 0.4 30.2 ± 0.6 
aMean and standard deviations of 3 determinations for diﬀerent samples (mg tablet-1 or  
mg  100 mL-1);  bOral  solutions  containing  guaiacol,  parabens  and  ephedrine; 
cTablets  containing  codeine,  ASA  and caﬀeine. 
 
 
 
Figure  5.    Flow injection analysis with amperometric detection of mmol L-1  codeine 
standards  solutions:  A—7.39,  B—10.1;  C—20.2,  D—30.2,  E—40.3,  F—50.4,  and 
pharmaceutical  samples:  G—Dolviran,  H—Nogrimine,  and  I—Codis,  under  the 
experimental  conditions  described. 
  
 
 
With this set of values, applying an orthogonal least squares ﬁtting, in all  cases  a  
linear  relationship  is  obtained  (CD ¼ C0 þ S CR,  with  C0 ¼ -0.8 and S ¼ 1.04) 
showing that there is a good agreement between the developed methods and the reference 
methods. The experimentally determined calibra- tion  parameters  were  compared,  with  
the  theoretically  expected  values  by means of Student’s t-test and, for a conﬁdence 
interval of 95%, a value of t lower than the critical value was obtained. The 
repeatability of the methods was  evaluated  by  performing  eleven  consecutive  
determinations  of  each  of the solutions to be analysed. The relative standard deviations 
obtained were less  than  3%. 
 
 
CONCLUSIONS 
 
The use of electroanalytical techniques SWV or FIA-EC with a glassy carbon 
electrode for codeine quantiﬁcation in pharmaceutical preparations proved to be a good 
alternative for the determination of codeine in most pharmaceutical preparations since 
it enables a fast, sensitive and selective analysis. Moreover, both proposed methods are 
simple, easy to operate, inexpensive and made unnecessary complex pre-treatment of the 
samples unnecessary. The results obtained suggest that this methodology could replace 
time-consuming and costly procedures and be easily implemented in any routine 
analytical  laboratory. 
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